Healthwell Acquisition I Past Earnings Performance
Past criteria checks 0/6
Healthwell Acquisition I's earnings have been declining at an average annual rate of -80.7%, while the Capital Markets industry saw earnings growing at 12.1% annually.
Key information
-80.7%
Earnings growth rate
-81.6%
EPS growth rate
| Capital Markets Industry Growth | 10.3% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Healthwell Acquisition I makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 0 | 2 | 2 | 0 |
| 31 Mar 23 | 0 | 6 | 1 | 0 |
| 31 Dec 22 | 0 | 11 | 1 | 0 |
| 30 Sep 22 | 0 | 7 | 2 | 0 |
| 30 Jun 22 | 0 | 13 | 1 | 0 |
| 31 Mar 22 | 0 | 10 | 1 | 0 |
Quality Earnings: HWEL has a large one-off gain of $9.4M impacting its last 12 months of financial results to 30th June, 2023.
Growing Profit Margin: Insufficient data to determine if HWEL's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if HWEL's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare HWEL's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Earnings vs Industry: HWEL had negative earnings growth (-80.7%) over the past year, making it difficult to compare to the Capital Markets industry average (2.4%).
Return on Equity
High ROE: HWEL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.